SEC Form 4 · accession 0000872574-18-000003

Kezar Life Sciences, Inc. · KZR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Other

Period of report

Jun 25, 2018

Accepted (ET)

Jul 5, 2018 · 9:28 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001645666

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 25, 2018	C	210,326	—	A	210,326	I	By revocable trust
Common Stock^F1	Jun 25, 2018	C	125,927	—	A	125,927	I	By revocable trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Convertible Preferred Stock^F1	—	Jun 25, 2018	C	210,326	D	—	—	Common Stock	210,326	0	I
Series B Convertible Preferred Stock^F1	—	Jun 25, 2018	C	125,927	D	—	—	Common Stock	125,927	0	I

F1Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.